- Molecular NameOxyphenbutazone
- Synonym1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione; 1-p-Hydroxyphenyl-2-phenyl-3,5-dioxo-4-N-butylpyrazolidine; 1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine; 3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl; 4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione; 4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione; 4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine; 4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedione; Hydroxyphenylbutazon; OPB; Ossifenbutazone [dcit]; Oxifenbutazona [inn-spanish]; Oxifenylbutazon; Oxiphenbutazone; Oxiphenbutazonum; Oxyphenbutazonum [inn-latin]; Oxyphenobutazone; Oxyphenylbutazone; P-hydroxyphenylbutazone; P-oxyphenylbutazone; Usaf Ge-14
- Weight324.38
- Drugbank_IDN/A
- ACS_NO129-20-4
- Show 2D model
- LogP (experiment)2.72
- LogP (predicted, AB/LogP v2.0)2.5
- pka4.7 (22)
- LogD (pH=7, predicted)-0.05
- Solubility (experiment)N/A
- LogS (predicted, ACD/Labs)(ph=7)-1.61
- LogSw (predicted, AB/LogsW2.0)0.2
- Sw (mg/ml) (predicted, ACD/Labs)0.09
- No.of HBond Donors1
- No.of HBond Acceptors5
- No.of Rotatable Bonds5
- TPSA60.85
- StatusN/A
- AdministrationN/A
- PharmacologyA metabolite of phenylbutazone.
- Absorption_value100.0
- Absorption (description)N/A
- Caco_2N/A
- BioavailabilityN/A
- Protein binding99.0
- Volume of distribution (VD)0.1 L/kg
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmN/A
- Half life~3 days
- ExcretionN/A
- Urinary ExcretionN/A
- CleranceN/A
- ToxicityN/A
- LD50 (rat)N/A
- LD50 (mouse)N/A